STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3854 by analyst upside · 2026-06-27
CCRN
Cross Country Healthcare, Inc.
Healthcare · Market Cap $427M · P/E 0x
ANALYST PRICE TARGET
-4.7%
implied upside to consensus target
Current Price $13.22
Consensus Target $12.6
Bull Target $13.25
Bear Target $10.0
Analysts Covering 5
ANALYST CONSENSUS — BUY
Strong Buy
1
Buy
1
Hold
3
Sell
0
52-Week Low $7.43
52-Week High $14.99
YTD Return +64.0%
FUNDAMENTALS
Market Cap $427M
P/E Ratio (TTM) N/A
Forward P/E 47.2x
EPS (TTM) $-3.05
PEG Ratio 12.57
Dividend Yield N/A
Revenue (TTM) $1.0B
Profit Margin -9.8%
52-WEEK RANGE
52-Week Low $7.43
52-Week High $14.99
Current Price $13.22
Bear Target $10.0
Bull Target $13.25
● Now $13.22 ● Target $12.6
TRADING DATA
Avg Volume 664K
YTD Return +64.0%
Analyst Count 5
Consensus Buy
Upside to Target -4.7%
Last Updated 2026-06-27

ANALYST SUMMARY

Cross Country Healthcare, Inc. (CCRN) is currently trading at $13.22 with a Wall Street consensus price target of $12.6, which is 4.7% below the current price over the next 12 months. 5 analysts currently cover CCRN, with a consensus rating of Buy — 40% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $13.25, while the most cautious has a target of $10.0.

CCRN operates in the Healthcare sector with a market capitalisation of $427M. The stock is up 64.0% year-to-date and is currently trading near the upper end of its 52-week range of $7.43 – $14.99.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CCRN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barrington Research — Reiterated
Market Perform → Market Perform 2026-06-08 Building track record
Truist Securities — Reiterated
Hold → Hold 2026-05-11 Building track record
Benchmark ↓ Downgrade
Buy → Hold 2026-05-08 Building track record
Wedbush ↓ Downgrade
Outperform → Neutral 2026-05-07 Building track record
Wedbush ↑ Upgrade
Neutral → Outperform 2026-03-19 Building track record
Benchmark ↑ Upgrade
Hold → Buy 2026-03-05 Building track record
Wedbush ● Initiated
Neutral 2026-02-03 Building track record
UBS — Reiterated
Neutral → Neutral 2025-12-09 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →